LNK01005

N/A

Report date: 2024/11/13 15:02:16
NME

Base Information

Drug NameLNK01005
Drug Alias NameLNK-01005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase JAK1Tyrosine-protein kinase 2
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A